Telemedicine Evaluation for Stem Cell Transplant Patients

Completed · Not applicable

Conditions studied: Stem Cell Transplant Patients

In brief

Telemedicine is a new area of health care where medical information is transferred through audiovisual media, such as a computer or a video camera, for the purpose of remote doctor's visits or examinations. This new area of health care is important to test because it can potentially provide real-time interactions between the patient and their health care team, including phone conversations, online communication, and/or home visits. Many activities such as a history review or physical examination can be conducted virtually as compared to the traditional face-to face visits. The purpose of this study is to determine patient and health care team acceptance of a "virtual medical visit" as a substitute for a "face to face" visit for patients either preparing to receive a stem cell transplant or previously received a stem cell transplant.

Key facts

Study ID

NCT01324427

Run by

Memorial Sloan Kettering Cancer Center

People needed

43

Starts

2011-03-01

Expected to finish

2020-08-01

Last updated by the study team

2020-08-14

Who can join

Age: 18 and older, up to 74. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who underwent or are planning to undergo a hematopoietic progenitor cell transplantation for any disease.
• Participants must be able to read and understand English*
• Age over 18 years of age since this pilot trial is only being performed in the Adult BMT Service Non-English speaking patients have been excluded in this pilot study because we do not have the support for translation services at this time. Additionally, the telemedicine instruments being used are not yet validated across all languages.
• Potential patients will be identified according to their medical condition, type and complexity of stem cell transplant procedure performed, and distance from MSKCC.
• The patients should:
• minimal comorbidities,
• be less than 75 years of age. These characteristics have been associated with good understanding and acceptance of telemedicine in other pilot trials. These characteristics will be assessed by the clinician.
• Please note: Patients on other therapeutic protocols will be eligible for this protocol as well.

You may not qualify if…

• Medically unstable patient as deemed by the treating team.

Where it is running

• Memoral Sloan Kettering Cancer Center — Basking Ridge, New Jersey, United States
• Memorial Sloan-Kettering Cancer Center @ Suffolk — Commack, New York, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States
• Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center — Sleepy Hollow, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.